Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro Internacional de Vacunas (CIV) is a prominent research organization based in Cali, Colombia, dedicated to the development and clinical testing of vaccines for tropical diseases, with a specific emphasis on malaria. The center operates as part of a collaborative scientific ecosystem alongside the Caucaseco Scientific Research Center and the Fundación Centro de Primates. CIV is globally recognized for its expertise in using Controlled Human Malaria Infection (CHMI) models and Aotus primate models to accelerate the transition of vaccine candidates from pre-clinical to clinical stages. Their work primarily targets Plasmodium vivax and Plasmodium falciparum, often in partnership with international bodies like the NIH and the Bill & Melinda Gates Foundation. The organization maintains advanced infrastructure for immunology, molecular biology, and parasitology to support both proprietary and collaborative global health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro Internacional de Vacunas.